Biomerica begins clinical study of proprietary H. Pylori test — 4 insights

Biomerica began a clinical study of its new, proprietary Helicobacter pylori test.

Advertisement

The test is designed to increase sensitivity and specificity of H. pylori testing.

Here’s what you should know:

1. The company is conducting a multisite study at Los Angeles-based University of Southern California, Nashville, Tenn.-based Vanderbilt University and at a European University.

2. Biomerica believes the study will take between six months to a year to complete.

3. After the study is complete, Biomerica will conduct analysis in anticipation of submitting the test to the FDA. Biomerica believes it’ll be able to utilize a 510(k) pathway clearance.

4. Biomerica CEO Zackary Irani said in a release the new product answers demand for an accurate and cost-effective test.

More articles on gastroenterology:
GI center to know: Lakeside Endoscopy Center
PPIs included on list of drugs to ‘seriously consider deprescribing’
GI leader to know: Dr. Douglas Brouillette of Midwest Gastrointestinal Associates

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.